https://www.selleckchem.com/GSK-3.html
Glycemic variability is associated with risks for adverse events in patients with cancer. Several studies have evaluated the presence and impact of hyperglycemia and/or hypoglycemia in patients with cancer; however, few studies have evaluated glycemic variability. The purpose of this integrative review of studies in patients with gastrointestinal cancers was to investigate the presence and methods of reporting glycemic variability during and following treatments. A comprehensive review of the literature was conducted. PubMed, CINAHL, EMBASE, and C
Like
Comment
Share
